Repligen Corporation completes patient enrollment in RG2417 Phase 2b clinical trial

Repligen Corporation reported today that it has completed enrollment of patients in its Phase 2b clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar depression.

Repligen Announces Completion of Patient Enrollment in Phase 2b Clinical Trial of RG2417 for Bipolar Depression

Repligen Corporation reported today that it has completed enrollment of patients in its Phase 2b clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar depression. Â This study is a double-blind, placebo-controlled trial designed to assess the efficacy of 8 weeks of treatment with RG2417 or a placebo on the symptoms of bipolar depression as measured by the Montgomery …

‘Bipolar’ defense no help to pot grower

Bipolar marijuana grower Charles Homan was convicted of possession with the intent to deliver at a bench trial Wednesday in York County court.

Science, society struggle with bipolar

CHICAGO, Sept. 29 (UPI) — As doctors learn more about the diagnosis and treatment of bipolar disorder, society is lagging behind in overcoming its social stigma, advocates say. Bipolar disorder – Mental health – disorder – Health – Mood

Bipolar disorder haunts family

Bipolar disorder has haunted Joan Fisher’s family for generations. With a new life in the balance, she puts her faith in new brain research. The baby in Joan Fisher’s arms looks perfect: full cheeks, a corona of wispy brown hair and wide, happy eyes through which she seems to take in the whole world.

Struggle and hope with bipolar disorder

Joan Fisher is placing her hope in the advance of science after generations in her family have been haunted by bipolar disorder Gazing at her granddaughter, Joan Fisher can see no trace of the legacy that has run through their family for generations. But she knows bipolar disorder could be there, hidden in the girl’s DNA, waiting to emerge.

USC, Las Encinas Hospital to study on schizophrenia, bipolar disorder in younger, older adults

Schizophrenia and bipolar disorder affect 3% to 4% of the world’s population, or about 222 million adults worldwide. In the United States, bipolar disorder affects about 5.7 million adult Americans 18 and older. Bipolar disorder, or manic depression, is a serious brain disorder that causes extreme shifts in mood, energy and functioning. People with the disorder experience episodes of mania and …

Bipolar disorder affects 3 percent of population

Denise Krischke is one of an estimated 3 percent of the population with bipolar disorder, a serious mental illness. It is a mood disorder, but people can develop loss of contact with reality.

Local Author Strives to Dispel Myths of Mental Illness

Where Are the Cocoa Puffs?: A Family Journey Through Bipolar Disorder published Sept. 21 As 18-year-old Amanda spirals into mania, her father, psychiatrist

News: Peer group helps individuals with bipolar disorder

Although it’s the busy season for contractors, Bill Goodhew drives to the Women’s Community Building every other Tuesday evening to host a peer support group for individuals or family members struggling with bipolar disorder.

Next Page »